Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis

References

• Wieser HG. ILAE Commission on neurosurgery of epilepsy. ILAE commission report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia. 2004;45:695–714.
   PubMed Web of Science ®Google Scholar
• Bien CG, Scheffer IE. Autoantibodies and epilepsy. Epilepsia. 2011;52:18–22.
   PubMed Web of Science ®Google Scholar
• Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–1098.
   PubMed Web of Science ®Google Scholar
• Vincent A, Crino PB. Systemic and neurologic autoimmune disorders associated with seizures or epilepsy. Epilepsia. 2011;52:12–17.
   PubMed Web of Science ®Google Scholar
• Quek AM, Britton JW, McKeon A, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012;69:582–593.
   PubMed Web of Science ®Google Scholar
• Peltola J, Kulmala P, Isojärvi J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology. 2000;55:46–50.
   PubMed Web of Science ®Google Scholar
• McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology. 2005;65:1730–1736.
   PubMed Web of Science ®Google Scholar
• Majoie HJ, de Baets M, Renier W, et al. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res. 2006;71:135–141.
   PubMed Web of Science ®Google Scholar
• Errichiello L, Perruolo G, Pascarella A, et al. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol. 2009;211:120–123.
   PubMed Web of Science ®Google Scholar
• Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain. 2012;135:1622–1638.
   PubMed Web of Science ®Google Scholar
• Liimatainen S, Peltola M, Sabater L, et al. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia. 2010;51:760–767.
   PubMed Web of Science ®Google Scholar
• Falip M, Carreño M, Miró J, et al. Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. Eur J Neurol. 2012;19:827–833.
   PubMed Web of Science ®Google Scholar
• Brenner T, Sills GJ, Hart Y, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia. 2013;54:1028–1035.
   PubMed Web of Science ®Google Scholar
• Ekizoglu E, Tuzun E, Woodhall M, et al. Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epilepsia. 2014;55:414–422.
   PubMed Web of Science ®Google Scholar
• Vanli-Yavuz EN, Erdag E, Tuzun E, et al. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry. 2016;87:684–692.
   PubMed Web of Science ®Google Scholar
• Bien CG, Urbach H, Schramm J, et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology. 2007;69:1236–1244.
   PubMed Web of Science ®Google Scholar
• Liimatainen S, Peltola J. Epilepsy associated with glutamic acid decarboxylase antibody (GADA). Eur J Neurol. 2012;19:799.
   PubMed Web of Science ®Google Scholar
• Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701–712.
   PubMed Web of Science ®Google Scholar
• Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electrographic classification of epileptic seizures. Epilepsia. 1981;22:489–501.
   PubMed Web of Science ®Google Scholar
• Blümcke I, Thom M, Aronica E, et al. The clinico-pathological spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE diagnostic methods commission. Epilepsia. 2011;52:158–174.
   PubMed Web of Science ®Google Scholar
• Blümcke I, Thom M, Aronica E, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE commission on diagnostic methods. Epilepsia. 2013;54:1315–1329.
   PubMed Web of Science ®Google Scholar
• Lin F, Chen Z. standardization of diagnostic immunohistochemistry. Arch Pathol Lab Med. 2014;138:1564–1577.
   PubMed Web of Science ®Google Scholar
• Malter MP, Helmstaedter C, Urbach H, et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol. 2010;67:470–478.
   PubMed Web of Science ®Google Scholar
• Carreño M, Bien CG, Asadi-Pooya AA, et al. Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies. Epilepsy Res. 2017;129:101–105.
   PubMed Web of Science ®Google Scholar
• Bien CG, Elger CE. Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav. 2007;10:529–538.
   PubMed Web of Science ®Google Scholar
• Urbach H, Soeder BM, Jeub M, et al. Serial MRI of limbic encephalitis. Neuroradiology. 2006;48:380–386.
   PubMed Web of Science ®Google Scholar
• Bien CG, Scheffer IE. Autoantibodies and epilepsy. Epilepsia. 2011;52:18–22.
   PubMed Web of Science ®Google Scholar
• Zattoni M, Mura ML, Deprez F, et al. Brain Infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci. 2011;31:4037–4050.
   PubMed Web of Science ®Google Scholar
• Nakahara H, Konishi Y, Beach TG, et al. Infiltration of T lymphocytes and expression of ICAM-1 in the hippocampus of patients with hippocampal sclerosis. Acta Histochem Cytochem. 2010;43:157–162.
   PubMed Web of Science ®Google Scholar
• Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol. 2002;51:311–318.
   PubMed Web of Science ®Google Scholar
• Mathern GW, Pretorius JK, Mendoza D, et al. Hippocampal N-methyl-D-aspartate receptor subunit mRNA levels in temporal lobe epilepsy patients. Ann Neurol. 1999;46:343–358.
   PubMed Web of Science ®Google Scholar
• Neder L, Valente V, Carlotti CG Jr, et al. Glutamate NMDA receptor subunit R1 and GAD mRNA expression in human temporal lobe epilepsy. Cell Mol Neurobiol. 2002;22:689–698.
   PubMed Web of Science ®Google Scholar
• Tüzün E, Zhou L, Baehring JM, et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol. 2009;118:737–743.
   PubMed Web of Science ®Google Scholar
• Tezer FI, Xasiyev F, Soylemezoglu F, et al. Clinical and electrophysiological findings in mesial temporal lobe epilepsy with hippocampal sclerosis, based on the recent histopathological classifications. Epilepsy Res. 2016;127:50–54.
   PubMed Web of Science ®Google Scholar